I remember a friend of mine telling me years ago that even though I had an MD after my name, I reminded him more of a chiropractor. That was in fact a high compliment as I’ve never been a fan of the traditional “bull in the china shop” medical approach. This past week, Josh Axe, …
Xue and colleagues show that prostaglandin E1 (PGE1) inhibits the activity and self-renewal of human CML leukemic stem cells. Combination of PGE1 or an agonist for its receptor EP4 with conventional tyrosine kinase inhibitor treatment can effectively target CML leukemic stem cells and reduce leukemia growth. This Post Originally Appeared at Cell Stem Cell
Dr. Riordan gave a talk about stem cell tourism. Here he is joined by “the father of the mesenchymal stem cell”, Arnold Caplan, Phd and Dr. Priscilla Ortiz. This Post Originally Appeared at CellMedicine.com
By Doug Oliver: I’m very positive about the future role of FDA in ensuring that stem cell and related therapies are safe and effective. And, because of that, I believe now is the appointed time for both patients AND therapy providers to be intentional in helping to rewire their own perspectives and consider what it …
The new Stanford Center for Definitive and Curative Medicine will work to turn discoveries into stem cell and gene therapies to aid the millions of people who have genetic diseases. This Post Originally Appeared at Stanford Medicine News Center
(Interview courtesy of Future Medicine) Bernard Siegel is the Founder and full-time Executive Director of the nonprofit Regenerative Medicine Foundation (FL, USA). He is the Founder and the Co-chair of the World Stem Cell Summit series of global conferences and Editor-in-Chief of the World Stem Cell Report. He received his undergraduate and law degrees from …
(Interview courtesy of Future Medicine) Bernard Siegel is the Founder and full-time Executive Director of the nonprofit Regenerative Medicine Foundation (FL, USA). He is the Founder and the Co-chair of the World Stem Cell Summit series of global conferences and Editor-in-Chief of the World Stem Cell Report. He received his undergraduate and law degrees from …
On December 2016, Mayor Bill De Blasio announced that the city’s next great industry is biotechnology. A lofty goal grounded in reality and backed with a $500 million funding commitment. Not long after this announcement, in April 2017, I visited New York to witness the opening of the New York Stem Cell Foundation (NYSCF) laboratories, one …
On December 2016, Mayor Bill De Blasio announced that the city’s next great industry is biotechnology. A lofty goal grounded in reality and backed with a $500 million funding commitment. Not long after this announcement, in April 2017, I visited New York to witness the opening of the New York Stem Cell Foundation (NYSCF) laboratories, one …
In December 2015, the Bipartisan Policy Center –a Washington, D.C. nonprofit think-tank– published a seminal paper entitled Advancing Regenerative Cellular Therapy -Medical Innovation Healthier Americans. This Report provided information about the nature of cell therapies, international competitive landscape and US regulatory analysis. Guiding the document was a blue-ribbon panel including experts and leaders from Duke …
Twelve years ago my nonprofit organization founded an annual conference that evolved into the World Stem Cell Summit. Over time, this event has brought together thousands of thought leaders and stakeholders from around the globe. All came with a shared passion, to expand their knowledge, forge collaborations, and ultimately deliver cures. We recently announced that our 13th World Stem …
By Samantha Bresnahan, CNN (CNN) Bill Marlette was a long way from home, but he was willing to take the risk, as there were really no other options. He was tired of the daily pain that made even shaking someone’s hand almost unbearable. Marlette lost his arm in an accident when he was a teenager, …